Home
Resources
Publications
Weaning From Parenteral Nutrition

Weaning From Parenteral Nutrition

Andrew Ukleja

Gastroenterol Clin North Am. 2019 Dec;48(4):525-550.

PMID: 31668181

Abstract:

The ultimate goal of treatment of short bowel syndrome/intestinal failure patients is to achieve enteral autonomy by eliminating parenteral nutrition (PN)/intravenous fluids (IV). After optimization of diet, oral hydration and anti-diarrheal medications, attempt should be made to eliminate PN/IV. Weaning from PN/IV should be individualized for each patient. Although teduglutide is the preferred agent for PN/IV volume reduction or successful weaning, optimal patient selection and long-term safety need further evaluation. Following PN/IV elimination, patients need long-term monitoring for nutritional deficiencies. This article will address clinical considerations before, during, and after PN/IV weaning to facilitate safe and successful PN/IV weaning process.

Chemicals Related in the Paper:

Catalog Number	Product Name	CAS Number	Price
AP1118032	Azidotrimethyltin(IV)	1118-03-2	Price
AP6148487	Bromotrimethyllead(IV)	6148-48-7	Price
AP993522	Hexamethyldigermanium(IV)	993-52-2	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: